• ALR Technologies (Richmond, Virginia) said William Smith has been named president of the company, effective May 19. Lawrence Weinstein, who served as president/COO of ALR Technologies since 2010, expressed a wish to pursue other activities and will remain as a consultant. Smith has served as director, commercial strategies and external affairs at ALR Technologies since February 2013. ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases.

• BioHealth Innovation (Rockville, Maryland) has named Shady Grove Adventist Hospital president John Sackett to its board. Sackett is filling a vacancy on the BHI board left by William Robertson, who recently said he was leaving his post as president/CEO of Adventist HealthCare for a position in Washington state. Sackett most recently served Centura as the CEO for Avista Adventist Hospital in Louisville, Colorado. BioHealth Innovation is a regional innovation intermediary focused on commercializing bio-health innovations and increasing access to early-stage funding in Maryland.

• Cancer Treatment Centers of America (CTCA; Schaumburg, Illinois) has named Kristin Darby, as its chief information officer. Darby served most recently as the CIO of the Northeast Region for Tenet Healthcare, overseeing the IT and Informatics functions at nine acute care hospitals as well as nearly 100 ancillary locations. Cancer Treatment Centers of America is a network of five hospitals that specialize in the treatment of patients fighting complex or advanced-stage cancer.

Mark O'Halla has been promoted to executive VP/chief operating officer of McLaren Health Care (Flint, Michigan) from president/CEO of McLaren Macomb. O'Halla joined McLaren in 2006 as president/CEO of McLaren Macomb, a 288-bed acute care hospital in Mount Clemens, Michigan. McLaren Health Care is a health network committed to quality evidence-based patient care and cost efficiency.

• OncoSec Medical (San Diego) has named Jean Campbell, PhD, as executive director of R&D. Campbell is an associate professor in the Department of Pathology in the School of Medicine at the University of Washington, Seattle. Prior to joining OncoSec Medical, Campbell was liaison for the Northwest Liver Research Program and a principal investigator of an R01-funded research laboratory. OncoSec Medical makes ImmunoPulse immunotherapy to treat solid tumors.

• Orthofix (Lewisville, Texas) has named David Ziegler as interim chief financial officer. Ziegler succeeds Emily Buxton who has voluntarily resigned from the company. Orthofix and its board are conducting an executive search to identify a permanent CFO. With more than 40 years' experience, Ziegler has held a wide range of CFO and consulting roles including serving as interim CFO of, and transition consultant to, Exopack Holding Corp., and a financial consultant to PetroLogistics. Orthofix offers reconstructive and regenerative orthopedic and spine solutions to physicians.

• PHT (Boston) reported the promotion of VP of service delivery Andrea Valente to chief operating officer. Prior to PHT, Valente was VP of global services, education and customer support at OpenPages. PHT is a provider of technologies used to collect patient-driven eData for clinical research.

No Comments